Skip to main content

Table 4 Effect sizes for within-group changes (WGCs) from T1 within each condition and effect sizes for between-group differences (BGDs) at each time point

From: Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C

PROMs

Condition

T1

T2

T3

T4

T5

WGC ESa

WGC ESa

WGC ESa

WGC ESa

HrQOL: physical well-being

CBCS

 

.44

.18

.18

.59

SC

 

− .47

.00

.20

.37

(BGD ESb)

(− .05)

(.92)

(.15)

(− .06)

(.23)

HrQOL: emotional well-being

CBCS

 

.33

.03

.52

.54

SC

 

.15

.70

1.07

1.00

(BGD ESb)

(.41)

(.51)

(− .29)

(− .14)

(− .19)

HrQOL total

CBCS

 

.39

− .02

.33

.51

SC

 

− .37

.03

.54

.90

(BGD ESb)

(.15)

(.86)

(.12)

(− .03)

(− .18)

HrQOL: social/family well-being

CBCS

 

.30

.03

.25

.34

SC

 

− .10

− .16

.32

.38

(BGD ESb)

(− .04)

(.30)

(.17)

(− .20)

(− .08)

HrQOL: functional well-being

CBCS

 

− .27

.05

− .18

− .28

SC

 

.66

.51

− .12

− .55

(BGD ESb)

(.16)

(1.16)

(.75)

(.24)

(− .10)

Perceived stress

CBCS

 

− .53

− .06

− .23

− .59

SC

 

.30

.12

− .30

− .54

(BGD ESb)

(− .19)

(− .90)

(− .37)

(− .06)

(− .06)

Anxiety

CBCS

 

− .43

− .46

− .26

− .55

SC

 

− .18

.01

− .28

− .37

(BGD ESb)

(.34)

(.22)

(− .10)

(.55)

(.30)

Depression

CBCS

 

− .28

− .02

− .26

− .55

SC

 

.14

.20

− .18

− .05

(BGD ESb)

(.27)

(− .14)

(.02)

(.25)

(− .26)

Sleep disturbance

CBCS

 

− .51

− .48

− .66

− .53

SC

 

− .28

.76

.92

− .03

(BGD ESb)

(.77)

(.44)

(− .46)

(− .81)

(.13)

Fatigue

CBCS

 

− .14

− .12

− .27

− .52

SC

 

.23

− .08

− .34

− .65

(BGD ESb)

(− .27)

(− .66)

(− .36)

(− .23)

(− .24)

Sleep-related impairment

CBCS

 

− .25

− .07

− .18

− .48

SC

 

.55

− .10

− .10

− .44

(BGD ESb)

(− .41)

(1.36)

(− .45)

(− .55)

(− .66)

Anger

CBCS

 

− .48

− .25

.00

− .46

SC

 

.11

.36

.08

.17

(BGD ESb)

(.14)

(− .37)

(− .46)

(.09)

(− .55)

Pain interference

CBCS

 

− .37

− .15

− .02

− .14

SC

 

− .14

− .12

− .67

− .73

(BGD ESb)

(− .53)

(− .70)

(− .54)

(.10)

(.02)

Pain intensity

CBCS

 

− .64

− .15

.14

− .05

SC

 

− .13

− .35

− .85

− .86

(BGD ESb)

(− .15)

(− .66)

(.03)

(.82)

(.62)

MOCS: relaxation

CBCS

  

1.06

1.53

1.33

SC

  

− .08

.43

.35

(BGD ESb)

(.06)

 

(1.08)

(.88)

(.55)

MOCS total

CBCS

  

.49

1.01

1.30

SC

  

− .04

.43

.44

(BGD ESb)

(− .13)

 

(.33)

(.47)

(.48)

MOCS: assertiveness

CBCS

  

.00

.33

1.14

SC

  

.03

.10

− .05

(BGD ESb)

(− .22)

 

(− .29)

(− .03)

(.66)

MOCS: coping confidence

CBCS

  

.08

.70

.99

SC

  

.07

.43

.52

(BGD ESb)

(.07)

 

(.05)

(.12)

(.13)

MOCS: awareness of tension

CBCS

  

.44

.83

.59

SC

  

− .18

.15

.54

(BGD ESb)

(− .29)

 

(.33)

(.52)

(− .27)

Tx self-efficacy: coping with Psych.

CBCS

  

.14

  

SC

  

− .45

  

(BGD ESb)

(− .31)

 

(.31)

  

Tx self-efficacy: coping with physical

CBCS

  

− .19

  

SC

  

.22

  

(BGD ESb)

(.61)

 

(.29)

  

Tx self-efficacy: patient Comm.

CBCS

  

− .52

  

SC

  

.29

  

(BGD ESb)

(.22)

 

(− .60)

  
  1. aWGC ES is the change over time in the same condition, from T1 to T2, T1 to T3, T1 to T4, and T1 to T5
  2. bBGD ES is the difference between the two conditions at each time point: T1, T2, T3, T4, and T5